Korro Bio, Inc. logo

KRRO Earnings Date: Nov 11, 2026 (Estimated) — Korro Bio, Inc.

NASDAQ

Updated

Price $14.02
Market Cap $206.5M
P/E -1.2
52W Range $5.20 – $42.70
Next Earnings · After close (est.)

When is KRRO's next earnings date?

Korro Bio, Inc. (KRRO) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.26 on revenue of $187,500.

How did KRRO do in its last earnings report?

In its most recent report on Aug 6, 2026 (Q2 2026), Korro Bio, Inc. posted EPS of -$1.07 versus the -$1.34 estimate, a beat of 19.6%. Revenue was $0 against a $214,286 estimate. The stock's 1-day post-earnings move was +5.4%.

How much does KRRO stock move after earnings?

KRRO beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 15.5% (up or down) in the day after earnings.

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-06Q2 2026-1.34-1.07+19.55%$0✅ Beat+5.39%+16.09%+1.04%
2026-05-07Q1 2026-1.91-1.69+11.52%$0✅ Beat-3.37%-16.04%-19.64%
2026-03-12Q4 2025-2.05-5.32-159.51%$1.3M❌ Miss+11.30%-3.83%+19.04%
2025-11-12Q3 2025-2.65-1.92+27.55%$1.1M✅ Beat-79.31%-79.60%-73.81%
2025-08-12Q2 2025-2.57-2.74-6.61%$1.5M❌ Miss+6.25%+31.03%+135.95%
2025-03-18Q4 2024-2.51-2.26+9.96%$2.3M✅ Beat-3.55%-4.11%-46.53%
2024-08-13Q2 2024-2.40-2.43-1.25%$0❌ Miss+9.21%+16.34%+11.22%
2024-05-14Q1 2024-2.51-2.44+2.79%$0✅ Beat+5.43%+1.50%-15.08%

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .